Artificial Intelligence and Expediting Drug Development
- 1. z Expediting Drug Development Using Artificial Intelligence Ashley Recchione HADM 506
- 2. z AI and Drug Development Objectives: Understanding Artificial Intelligence FDA’s role in drug development today How Artificial Intelligence is changing lives
- 3. z What is Artificial Intelligence and the FDA? the theory and development of computer systems able to perform tasks that normally require human intelligence, such as visual perception, speech recognition, decision- making, and translation between
- 4. z Who is the FDA? The Food and Drug Administration is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation.
- 5. z FDA’s Phases of the Drug Developme nt Process Phase 1: Discovery Phase 2: Pre-Clinical Research Phase 3: Clinical Research Phase 4: FDA Drug Review Phase 5: Post-Market Drug Safety Monitoring
- 6. z
- 7. z FDA’s Strategies for Hastening Drug Development
- 8. z Evolution of Healthcare Without AI Average approval time of 10-12 years More than 25,000 deaths due to delay of cancer treatments annually. Use of paper records and human testing for treatment solutions Harmful drugs make it to shelves, causing death or deformity With AI Average approval time of less than 1 year Reduction in deaths due to delayed death by more than 50% Large databases to withhold patient information and genotype With a better forecasting ability, the drugs development can be halted or modified prior to human harm
- 9. z References https://www.fda.gov/ForPatients/Approvals/Fast/ucm20041766.h tm https://www.pfizer.com/science/clinical-trials/trial-data-and- results https://www.bio.org/sites/default/files/Clinical%20Development% 20Success%20Rates%202006-2015%20- %20BIO,%20Biomedtracker,%20Amplion%202016.pdf https://pharmaphorum.com/views-and-analysis/ai-blockchain- big-data-can-reduce-drug-development-costs/